BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 24512489)

  • 1. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
    Chen S; Okahara F; Osaki N; Shimotoyodome A
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
    Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
    Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Link between GIP and osteopontin in adipose tissue and insulin resistance.
    Ahlqvist E; Osmark P; Kuulasmaa T; Pilgaard K; Omar B; Brøns C; Kotova O; Zetterqvist AV; Stancáková A; Jonsson A; Hansson O; Kuusisto J; Kieffer TJ; Tuomi T; Isomaa B; Madsbad S; Gomez MF; Poulsen P; Laakso M; Degerman E; Pihlajamäki J; Wierup N; Vaag A; Groop L; Lyssenko V
    Diabetes; 2013 Jun; 62(6):2088-94. PubMed ID: 23349498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
    Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
    Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes.
    Nie Y; Ma RC; Chan JC; Xu H; Xu G
    FASEB J; 2012 Jun; 26(6):2383-93. PubMed ID: 22366643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women.
    Rudovich N; Kaiser S; Engeli S; Osterhoff M; Gögebakan O; Bluher M; Pfeiffer AF
    Regul Pept; 2007 Aug; 142(3):138-45. PubMed ID: 17395281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
    Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
    Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
    Kim SJ; Nian C; McIntosh CH
    Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
    Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
    Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes.
    Timper K; Grisouard J; Sauter NS; Herzog-Radimerski T; Dembinski K; Peterli R; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E1-13. PubMed ID: 23092914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
    Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Fat Diet During Mouse Pregnancy and Lactation Targets GIP-Regulated Metabolic Pathways in Adult Male Offspring.
    Kruse M; Keyhani-Nejad F; Isken F; Nitz B; Kretschmer A; Reischl E; de las Heras Gala T; Osterhoff MA; Grallert H; Pfeiffer AF
    Diabetes; 2016 Mar; 65(3):574-84. PubMed ID: 26631738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism.
    Killion EA; Chen M; Falsey JR; Sivits G; Hager T; Atangan L; Helmering J; Lee J; Li H; Wu B; Cheng Y; Véniant MM; Lloyd DJ
    Nat Commun; 2020 Oct; 11(1):4981. PubMed ID: 33020469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
    Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation.
    Varol C; Zvibel I; Spektor L; Mantelmacher FD; Vugman M; Thurm T; Khatib M; Elmaliah E; Halpern Z; Fishman S
    J Immunol; 2014 Oct; 193(8):4002-9. PubMed ID: 25217161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.